Aidian Oy - Finnish Leader in Point-of-Care Diagnostic Solutions

Company Profile (Updated April 2026)

Aidian Oy is a leADINg Finnish in vitro diagnostics (IVD) company dedicated to developing, manufacturing, and distributing Rapid, reliAble, and easy-to-use diagnostic tests for point-of-care (POC) testing. Founded in 1974 as Orion Diagnostica and headquartered in Espoo, Finland, Aidian has nearly 50 years of expertise in providing diagnostic solutions that enable healthcare professionals to make accurate treatment decisions at the point of care.

The company operates with a mission to promote efficient and fluent healthcare through accurate and fast diagnostics while combating antimicrobial resistance (AMR)—one of the biggest threats to global health. With approximately 273-330 dedicated employees (reflecting recent growth trends) and annual revenue of approximately €55 million, Aidian serves customers in over 60 countries worldwide through direct sales organizations and collaboration partners.

Corporate History & Evolution

Founded: 1974 (as Orion Diagnostica Oy)
   Headquarters: Koivu-Mankkaan tie 6 B, FI-02200 Espoo, Finland
   Company Type: Private Limited Company
   Ownership: Nordstjernan (majority owner) and Ferd (33% stake acquired April 2022)
   Employees: ~273-330 (estimated, reflecting growth trajectory)
   Annual Revenue: ~€55 million (~$43.2M USD estimated)
   Website: www.aidian.eu

Key Milestones:

- 1974: Established as Orion Diagnostica, beginning development of diagnostic tests for healthcare

- 2016: Company rebranded from Orion Diagnostica to Aidian Oy, refocusing on core IVD business and expanding international presence

- 2022: Norwegian investment company Ferd acquired 33% stake in Aidian, joining Nordstjernan as co-owners to support international growth

- 2023: Awarded Finland's Best TES Workplace, recognizing excellence in employee relations and working conditions

- Present: Expanding product portfolio and global presence with focus on AMR prevention and primary care diagnostics

Revolutionary Product Portfolio

QuikRead go® System (Flagship Platform)

The QuikRead go is Aidian's flagship compact, fully automatic point-of-care testing system designed for primary healthcare settings. With approximately 50,000-60,000 instruments deployed globally (depending on data source and timing), the system provides quantitative and qualitative measurements through an intuitive touchscreen interface with 23 language options.

Key Features:

- User-Friendly Design: Large interactive touchscreen with animated user guidance; minimal hands-on time required

- Connectivity: Three USB ports for memory sticks, printers, and barcode readers; LIS/HIS connectivity for seamless data integration

- Fast Results: 2-6 minutes depending on analyte

- Traceability: Automatic result storage with patient/operator ID linking

- Portability: Compact size (27 x 15.5 x 14.5 cm, 1.7 kg) suitable for various healthcare sites

Diagnostic Applications

Infectious Disease & AMR Management:

- QuikRead go CRP: C-reactive protein testing to guide rational antibiotic prescribing and combat antimicrobial resistance

- Strep A Test: Rapid detection of streptococcus bacteria in throat infections

- Uricult Series: Urinary tract infection (UTI) diagnostic dipslides (CLED, MacConkey, Enterococcus, E.coli media)

Diabetes Management:

- HbA1c Testing: Glycated hemoglobin measurement for diabetes monitoring

Colorectal Cancer Screening:

- iFOBT (Immunochemical Fecal Occult Blood Test): Fecal immunochemical test kits for early colorectal cancer detection

Hematology:

- Hemoglobin Testing: Rapid hemoglobin measurement from capillary blood samples

Hygiene Monitoring

Aidian provides easy-to-use products for hygiene monitoring for hospitals and industrial applications, supporting infection control and environmental safety.

Global Market Presence

Geographic ReACH: Aidian operates in over 60 countries with a strong presence in Europe and expanding markets in Asia.

Local Offices (12 Countries):

- Nordics: Sweden, Norway, Denmark

- Western Europe: Germany, Netherlands, Belgium

- Central & Eastern Europe: Czech Republic, Slovakia, Hungary, Poland, Estonia

- Asia: China

Key Market: Finland, where Aidian holds a leading market position in point-of-care diagnostics

Quality Standards & Regulatory Compliance

Certifications:

- ISO 13485: Full quality management system certification for medical device manufacturing

- FDA Compliance: Products meet FDA requirements for US market access

- CE Marking (IVDR): In Vitro Diagnostic Regulation (IVDR) CE marked diagnostic tests for European market compliance

- Manufacturing: All production and most R&D operations located in Finland, ensuring high-quality standards

Strategic Focus: Combating Antimicrobial Resistance (AMR)

Aidian has positioned itself at the forefront of the global fight against antimicrobial resistance (AMR), recognized by the WHO as one of the top 10 global public health threats. The company's CRP point-of-care testing solutions enable:

- Rational Antibiotic Prescribing: Fast, accurate CRP testing supports clinical management of acute infections and optimizes antibiotic use

- Diagnostic Certainty: Increases confidence in distinguishing bacterial infections (requiring antibiotics) from viral infections (not requiring antibiotics)

- Sustainable Healthcare: Reduces unnecessary antibiotic prescriptions, slowing the development of antibiotic-resistant bacteria

By promoting "testing before prescribing," Aidian helps healthcare professionals make evidence-based treatment decisions that preserve antibiotic effectiveness for future generations.

Manufacturing & Operations

Headquarters & Production: Espoo, Finland
   Manufacturing Philosophy: All manufacturing plants and most R&D operations are located in Finland, ensuring strict quality control and regulatory compliance.

Contract Manufacturing Partnership: Innokas Medical manufactures QuikRead go® devices at their Kempele factory in Finland, supporting Aidian's production capacity and quality standards.

Leadership:

- CEO: Juho Himberg

- Supply Chain Vice President: Olli Rautee, recognized for excellence in employee relations and workplace culture

2026 Outlook & Strategic Vision

Product Innovation: Continued development of the QuikRead go platform, expanding test menu and enhancing connectivity features for integrated healthcare systems.

Global Expansion: Strengthening presence in existing European markets while expanding into emerging markets in Asia and other regions through strategic partnerships.

AMR Leadership: Expanding educational initiatives and product offerings to support global antimicrobial stewardship programs.

Market Growth: Capitalizing on growing point-of-care testing market trends, particularly in infectious disease diagnostics, diabetes management, and cancer screening.

Technology Integration: Enhancing digital connectivity and data management capabilities to support modern healthcare information systems and telemedicine applications.

Contact Information

Global Headquarters

Company: Aidian Oy
   Address: Koivu-Mankkaan tie 6 B, FI-02200 Espoo, Finland
   Phone: +358 10 309 3000
   Email: aidian@aidian.eu
   Website: www.aidian.eu

Regional Offices

Europe: Sweden, Norway, Denmark, Germany, Czech Republic, Slovakia, Hungary, Poland, Netherlands, Belgium, Estonia
   Asia: china

Keywords: Aidian Oy,艾迪安,Orion Diagnostica,Finland,point-of-care diagnostics,POCT,QuikRead go,CRP test,antimicrobial resistance,AMR,in vitro diagnostics,primary care,rapid diagnostic tests,Espoo,QuikRead go Plus,colorectal cancer screening,diabetes management,HbA1c,Strep A test,Uricult,iFOBT,ISO 13485,FDA,Finland Best Workplace 2023,60 countries,50,000 instruments,60,000 instruments,€55 million revenue,273 employees,330 employees,Nordstjernan,Ferd,Juho Himberg,Innokas Medical